No additive impact on patient survival of the double alteration of p53 and c-erbB-2 in breast carcinomas.

Journal of the National Cancer Institute

Volumn 88, Issue 14, 1996, Pages 1002-1003

  Menard S ^a   Casalini, P ^a   Pilotti, S ^a   Cascinelli, N ^a   Rilke, F ^a   Colnaghi, M I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P53;

BREAST TUMOR; CANCER STAGING; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE METASTASIS; MORTALITY; MUTATION; PATHOLOGY; PROTO ONCOGENE; SURVIVAL; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; FEMALE; GENES, ERBB-2; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MUTATION; NEOPLASM STAGING; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030591580     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.14.1002     Document Type: Letter

References (0)